Effectiveness of Paxlovid - a review

Abstract excerpt

Paxlovid is an oral treatment for mild to moderate COVID-19 cases with a high risk for severe course of the disease. For this review, we have performed a comprehensive literature review. We present a summary of currently available data on Paxlovid’s ability to reduce the risk of progressing to a severe disease state. Our findings can be concluded as follows: data from the time when the Delta-variant was dominant s...

Topics

Open a Topic to create a Post that cites this publication.

• COVID-19 Clinical Research Studies
• Insect symbiosis and bacterial influences
• Malaria Research and Control
• Mosquito-borne diseases and control
• PARP inhibition in cancer therapy
• SARS-CoV-2 and COVID-19 Research

Identifiers and source

Literature Corpus work

7710c3cd-0d44-5c15-9278-013acb7c93e1

DOI

10.1101/2023.01.13.23284506